HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation

E.A.H. Lanters, D.M.S. van Marion, C. Kik, H. Steen, A.J.J.C. Bogers, M.A. Allessie, B.J.J.M. Brundel, N.M.S. de Groot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)347
JournalJournal of Translational Medicine
Volume13
DOIs
Publication statusPublished - 2015

Cite this